Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CQ2 from our risk checks.
Cannae Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$20.40 |
52 Week High | US$20.60 |
52 Week Low | US$15.00 |
Beta | 0.89 |
1 Month Change | 0% |
3 Month Change | 14.61% |
1 Year Change | 17.24% |
3 Year Change | -38.18% |
5 Year Change | -6.29% |
Change since IPO | 28.14% |
Recent News & Updates
Recent updates
Shareholder Returns
CQ2 | DE Diversified Financial | DE Market | |
---|---|---|---|
7D | 2.0% | 3.1% | 1.9% |
1Y | 17.2% | 6.2% | 7.3% |
Return vs Industry: CQ2 exceeded the German Diversified Financial industry which returned 4.3% over the past year.
Return vs Market: CQ2 exceeded the German Market which returned 6.4% over the past year.
Price Volatility
CQ2 volatility | |
---|---|
CQ2 Average Weekly Movement | 3.9% |
Diversified Financial Industry Average Movement | 3.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CQ2 has not had significant price volatility in the past 3 months.
Volatility Over Time: CQ2's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 7,741 | Bill Foley | https://www.cannaeholdings.com |
Cannae Holdings, Inc. is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes.
Cannae Holdings, Inc. Fundamentals Summary
CQ2 fundamental statistics | |
---|---|
Market cap | €1.49b |
Earnings (TTM) | -€289.36m |
Revenue (TTM) | €526.28m |
2.8x
P/S Ratio-5.1x
P/E RatioIs CQ2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CQ2 income statement (TTM) | |
---|---|
Revenue | US$570.00m |
Cost of Revenue | US$527.00m |
Gross Profit | US$43.00m |
Other Expenses | US$356.40m |
Earnings | -US$313.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -4.32 |
Gross Margin | 7.54% |
Net Profit Margin | -54.98% |
Debt/Equity Ratio | 5.1% |
How did CQ2 perform over the long term?
See historical performance and comparison